Literature DB >> 24503815

Dilated perivascular spaces in small-vessel disease: a study in CADASIL.

Ming Yao1, Dominique Hervé, Eric Jouvent, Marco Duering, Sonia Reyes, Ophelia Godin, Jean Pierre Guichard, Martin Dichgans, Hugues Chabriat.   

Abstract

BACKGROUND AND AIM: Dilated perivascular spaces (dPVS) have previously been associated with aging and hypertension-related cerebral microangiopathy. However, their risk factors, radiological features and clinical relevance have been poorly evaluated in CADASIL (cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy), a unique model to investigate the pathophysiology of ischemic small-vessel disease. The purpose of this study was to investigate these different aspects in a large cohort of patients with this disorder.
METHODS: Demographic and MRI data of 344 patients from a prospective cohort study were analyzed. The severity of dPVS was evaluated separately in the anterior temporal lobes, subinsular areas, basal ganglia and white matter, using validated semiquantitative scales. Logistic and multiple linear regression models were used to determine the risk factors associated with the severity of dPVS in these different regions and their relationships with cognition, disability and the MRI markers of the disease (white matter hyperintensities (WMH) lacunar infarcts, microbleeds and brain parenchymal fraction (BPF)).
RESULTS: The severity of dPVS was found to increase with age regardless of cerebral area (p<0.001). In contrast with dPVS in other locations, the severity of dPVS in the temporal lobes or subinsular areas was also found strongly and specifically related to the extent of WMH (p<0.001). Conversely, no significant association was detected with lacunar volume, number of microbleeds or BPF. A high degree of dPVS in the white matter was associated with lower cognitive performances independently of age and other MRI markers of the disease including BPF (p≤0.04).
CONCLUSIONS: In CADASIL, the progression of the hereditary microangiopathy with aging may promote the dilation of perivascular spaces throughout the whole brain but with variable extent according to cerebral location. In temporal lobes and subinsular areas, dPVS are common MRI features and may share a similar pathogenesis with the extension of WMH during the course of the disease. dPVS may also participate in the development of cognitive decline in this model of small-vessel disease, and their large number in white matter may alert clinicians to a higher risk of cognitive decline in CADASIL.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 24503815     DOI: 10.1159/000356982

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  26 in total

Review 1.  Imaging characteristics of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL).

Authors:  Dragan Stojanov; Slobodan Vojinovic; Aleksandra Aracki-Trenkic; Aleksandar Tasic; Daniela Benedeto-Stojanov; Srdjan Ljubisavljevic; Sasa Vujnovic
Journal:  Bosn J Basic Med Sci       Date:  2015-02-09       Impact factor: 3.363

Review 2.  Clinical and research applications of magnetic resonance imaging in the study of CADASIL.

Authors:  Dorothee Schoemaker; Yakeel T Quiroz; Heirangi Torrico-Teave; Joseph F Arboleda-Velasquez
Journal:  Neurosci Lett       Date:  2019-01-08       Impact factor: 3.046

Review 3.  Perivascular spaces, glymphatic dysfunction, and small vessel disease.

Authors:  Humberto Mestre; Serhii Kostrikov; Rupal I Mehta; Maiken Nedergaard
Journal:  Clin Sci (Lond)       Date:  2017-08-10       Impact factor: 6.124

Review 4.  Consensus statement for diagnosis of subcortical small vessel disease.

Authors:  Gary A Rosenberg; Anders Wallin; Joanna M Wardlaw; Hugh S Markus; Joan Montaner; Leslie Wolfson; Costantino Iadecola; Berislav V Zlokovic; Anne Joutel; Martin Dichgans; Marco Duering; Reinhold Schmidt; Amos D Korczyn; Lea T Grinberg; Helena C Chui; Vladimir Hachinski
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

5.  NOTCH3 mutations in a cohort of Portuguese patients within CADASIL spectrum phenotype.

Authors:  Maria Rosário Almeida; Inês Elias; Carolina Fernandes; Rita Machado; Orlando Galego; Gustavo Santo
Journal:  Neurogenetics       Date:  2021-12-01       Impact factor: 2.660

Review 6.  Understanding the role of the perivascular space in cerebral small vessel disease.

Authors:  Rosalind Brown; Helene Benveniste; Sandra E Black; Serge Charpak; Martin Dichgans; Anne Joutel; Maiken Nedergaard; Kenneth J Smith; Berislav V Zlokovic; Joanna M Wardlaw
Journal:  Cardiovasc Res       Date:  2018-09-01       Impact factor: 10.787

7.  Association Between Subclinical Brain Infarcts and Functional Decline Trajectories.

Authors:  Mandip S Dhamoon; Ying-Kuen Cheung; Janet T DeRosa; Jose Gutierrez; Yeseon P Moon; Ralph L Sacco; Mitchell S V Elkind; Clinton B Wright
Journal:  J Am Geriatr Soc       Date:  2018-09-25       Impact factor: 5.562

8.  SQSTM1 gene as a potential genetic modifier of CADASIL phenotype.

Authors:  Maria Rosário Almeida; Ana Rita Silva; Inês Elias; Carolina Fernandes; Rita Machado; Orlando Galego; Gustavo Cordeiro Santo
Journal:  J Neurol       Date:  2020-11-20       Impact factor: 4.849

9.  Global and Regional Changes in Perivascular Space in Idiopathic and Familial Parkinson's Disease.

Authors:  Erin K Donahue; Amjad Murdos; Michael W Jakowec; Nasim Sheikh-Bahaei; Arthur W Toga; Giselle M Petzinger; Farshid Sepehrband
Journal:  Mov Disord       Date:  2021-01-20       Impact factor: 10.338

Review 10.  Perivascular spaces in the brain: anatomy, physiology and pathology.

Authors:  Joanna M Wardlaw; Helene Benveniste; Maiken Nedergaard; Berislav V Zlokovic; Humberto Mestre; Hedok Lee; Fergus N Doubal; Rosalind Brown; Joel Ramirez; Bradley J MacIntosh; Allen Tannenbaum; Lucia Ballerini; Ravi L Rungta; Davide Boido; Melanie Sweeney; Axel Montagne; Serge Charpak; Anne Joutel; Kenneth J Smith; Sandra E Black
Journal:  Nat Rev Neurol       Date:  2020-02-24       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.